doi: 10.1016/j.bmcl.2010.01.090.
Epub 2010 Jan 25.
The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure
Affiliations
- PMID: 20153647
- DOI: 10.1016/j.bmcl.2010.01.090
Item in Clipboard
The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure
Bioorg Med Chem Lett.
.
Abstract
The identification of a highly selective D(2) partial agonist, D(3) antagonist tool molecule which demonstrates high levels of brain exposure and selectivity against an extensive range of dopamine, serotonin, adrenergic, histamine, and muscarinic receptors is described.
Copyright 2010 Elsevier Ltd. All rights reserved.
Similar articles
-
Synthesis and pharmacological evaluation of potent and highly selective D3 receptor ligands: inhibition of cocaine-seeking behavior and the role of dopamine D3/D2 receptors.J Med Chem. 2003 Aug 28;46(18):3822-39. doi: 10.1021/jm0211220. J Med Chem. 2003. PMID: 12930145
-
In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.Synapse. 2006 Dec 15;60(8):599-608. doi: 10.1002/syn.20330. Synapse. 2006. PMID: 17001660
-
[3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.J Pharmacol Exp Ther. 1995 Sep;274(3):1558-65. J Pharmacol Exp Ther. 1995. PMID: 7562534
-
Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.J Med Chem. 2005 Jun 2;48(11):3663-79. doi: 10.1021/jm040190e. J Med Chem. 2005. PMID: 15916415 Review. No abstract available.
-
Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance.Curr Opin Pharmacol. 2010 Feb;10(1):100-7. doi: 10.1016/j.coph.2009.10.001. Epub 2009 Nov 5. Curr Opin Pharmacol. 2010. PMID: 19896900 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
